Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-31 to 2024-08-01
Current total value of award: $6214.22
Description: 4565305714!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML